FDA revokes approval for Covid antibody drugs that don’t work against Omicron

The Food and Drug Administration (FDA) has revoked its approval for Covid-19 antibody drugs that don’t work against the highly transmissible Omicron variant.

Subscribe
Notify of
guest
0 Comments
Inline Feedbacks
View all comments